Distal Ulna Excision for Giant Cell Tumor-Retrospective Functional Outcome and Recurrence Analysis from Single Tertiary Center

远端尺骨切除术治疗巨细胞瘤——来自单一三级中心的回顾性功能预后及复发分析

阅读:1

Abstract

Giant cell tumor of bone (GCTB) is classified as an intermediate malignant bone tumor, and occurrences in the distal ulna are particularly rare. This study aims to evaluate the outcomes of treating GCTB in the distal ulna through wide excision. We conducted a retrospective analysis at a single center, focusing on patients with GCTB of the distal ulna. The study included six nonmetastatic patients (5 males, 1 female; mean age 31 years, range 19-48 years) who underwent wide excision of the tumor without reconstruction. All patients followed a physiotherapy protocol. The mean follow-up period was 20 months, ranging from 12 to 54 months. Mean resection length was 8.3 cm. There were no cases of local recurrence and distal metastasis. At the latest follow-up, mean grip strength was 81% compared to the normal side, mean Modified Mayo wrist score was 83, and mean Patient Rated Wrist/Hand Evaluation (PRWHE) score was 23. Ulnar carpal translation was not present. For giant cell tumors of the distal ulna, we recommend en bloc excision with adequate margins, irrespective of Campanacci grade, without the necessity for reconstruction.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。